A Brain Implant for Depression Is About to Be Tested in Humans

Motif Neurotech's FDA-approved brain implant for treatment-resistant depression represents a significant emerging medical technology that will require IT infrastructure for wireless data transmission, patient monitoring systems, and secure health records management. As brain-computer interfaces advance toward clinical deployment, CIOs must prepare enterprise systems to support medical device connectivity, real-time biometric data streams, and compliance with evolving healthcare AI regulations. This emerging category of biotech-IT integration will demand new expertise in medical device cybersecurity, patient data privacy, and the interoperability standards necessary to scale these therapies from pilot studies to widespread clinical use.